MARSHALL WACE, LLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1318757 LONDON, X0

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$67,052,628

+$17,576,227 QoQ

Shares Held

508,977

+45.9% QoQ

Ownership

0.506%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (12.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	9,349,817	$126,316,026
2	NBIX	Neurocrine Biosciences Inc This page	508,977	$67,052,628
3	LNTH	Lantheus Holdings, Inc.	611,747	$46,401,008
4	UTHR	UNITED THERAPEUTICS Corp	75,977	$45,052,841
5	RDY	Dr Reddys Laboratories Ltd	2,664,306	$36,900,638
6	ALKS	Alkermes plc.	999,322	$35,336,024
7	ELAN	Elanco Animal Health Inc	1,382,412	$33,081,118
8	COLL	Collegium Pharmaceutical, Inc	748,812	$24,763,212

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,052,628	508,977	+45.9%	Shares	Other	2026-05-15
2025-12-31	$49,476,401	348,843	+258.6%	Shares	Other	2026-02-13
2025-09-30	$13,657,429	97,289	+133.6%	Shares	Other	2025-11-13
2025-06-30	$5,234,861	41,649	+1617.5%	Shares	Other	2025-08-13
2024-12-31	$331,012	2,425	-92.6%	Shares	Other	2025-02-13
2024-03-31	$4,548,049	32,976	-79.7%	Shares	Other	2024-05-15
2023-03-31	$16,466,773	162,683	+434.3%	Shares	Other	2023-05-15
2022-12-31	$3,636,470	30,446	+188.5%	Shares	Other	2023-02-14
2021-12-31	$898,799	10,553	-86.6%	Shares	Other	2022-02-14
2020-12-31	$7,576,367	79,044	-46.2%	Shares	Sole	2021-02-16
2020-09-30	$14,130,038	146,943	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.